Or is it the host, sir?
Mascolini
M
M
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D016753:Interleukin-10 / Q000502:physiology; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000517:prevention & control; D009181:Mycoses / Q000150:complications / Q000188:drug therapy; D013792:Thalidomide / Q000627:therapeutic use; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000096:biosynthesis
D000276:Adjuvants, Immunologic; D000890:Anti-Infective Agents; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D013792:Thalidomide